Teaching patients about their pills: a simple fix for better mental health?
NCT ID NCT07374588
First seen Jun 27, 2026 · Last updated Aug 25, 2026 · Updated 2 times
Summary
This study looks at whether teaching people in the hospital about their psychiatric medications helps them stick to their treatment and handle side effects. Researchers will work with 64 adults who have serious mental illnesses like schizophrenia or bipolar disorder. The goal is to see if a structured education program improves how well patients follow their medication plan.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
64 people
The number who actually took part.
- Started
-
Jan 2026
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18-65 years * Hospitalized in a psychiatric inpatient clinic * Diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, bipolar disorder with psychotic features, or major depressive disorder with psychotic features * Receiving psychotropic medication treatment * Clinically stable and able to participate in educational sessions * Able to communicate verbally and understand the content of the education * Provided written informed consent Exclusion Criteria: * Presence of severe cognitive impairment or intellectual disability * Acute medical or neurological conditions that may interfere with participation * Severe agitation or acute psychotic symptoms preventing participation * Hearing or communication impairments that limit participation in educational sessions * Participation in another psychosocial intervention study during the study period
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bipolar disorder with psychotic features are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sivas Cumhuriyet Univesity Hospital
Sivas, Sivas, 58400, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may reveal if You're taking your psychiatric medication
- Scientists probe brain's reward system in mental illness
- New schizophrenia drug targets brain glutamate, not dopamine
- New drug candidate takes aim at schizophrenia symptoms
- New schizophrenia drug goes Head-to-Head with standard antipsychotics in Long-Term trial
- Five-Year safety check for experimental schizophrenia drug